Securing your supply chain 

Werfen Immunoassay manufacturing capabilities oriented to provide high quality products to our partners     

In today’s evolving market—and in the years ahead—major IVD players face the challenge of meeting increased demand for IVD products while staying innovative, reliable, and committed to quality.

With our extensive experience in immunoassay development and manufacturing, we understand the challenges you may encounter as an immunoassay manufacturer. Whether it's scaling up production to meet growing demand for finished immunoassays or ensuring a consistent supply of critical IVD biomaterials like antigens and antibodies, we’re here to support you. 

At Werfen, we work alongside our partners to help them meet their operational and quality needs.

Background

During the R&D phase, new immunoassays are developed at bench scale. Once this stage is complete, the product transitions to assay manufacturing, where the manufacturing process is designed and validated based on demand forecasts.

However, throughout the lifecycle of an immunoassay, various challenges may arise. For instance, manufacturing volumes may no longer align with current demand, or production timelines may prove inefficient. In such cases, scaling up the immunoassay manufacturing process becomes a critical consideration to meet evolving requirements effectively.

Our Approach

When supplying immunoassays to the IVD industry, it’s essential to align with the evolving needs of your partners. This requires the ability to adapt to potential increases in demand seamlessly and efficiently.

Discover more about our immunoassay scale-up capabilities in the OEM Series: Securing your supply chain: Immunoassay scale-up capabilities to meet your increase in demand.